Wenbin Jiang, President and CEO at Cytek Biosciences, Inc. (CTKB), sold 20,000 shares at $12.58 ($253K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Open-market sale of $253k CTKB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.58 | 18,800 | $237K | 93.5% |
| 2 | $13.79 | 1,200 | $17K | 6.5% |
| Total | $12.65 avg | 20,000 | $253K | 100% |
| Filing → |
| CTKB | SELL | 2023-09-08 | $137K | — | Filing → |
| CTKB | SELL | 2023-08-08 | $362K | — | Filing → |
| CTKB | SELL | 2023-07-07 | $170K | — | Filing → |